Skip to content

Equinoxe 308-02-13Recalls & reported problems

Exactech, Inc. · Class 2 · Implant

All models of Equinoxe (305)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10885862267986), received between Nov 26, 2024 and Nov 26, 2024 — classified as 1 injury.

The most frequently reported specific device problem is “Loosening of Implant Not Related to Bone-Ingrowth” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 1 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Loosening of Implant Not Related to Bone-Ingrowth1

Patient problems

  • Loss of Range of Motion1
  • Pain1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 26, 2024Loosening of Implant Not Related to Bone-Ingrowth; Loosening of Implant Not Related to Bone-Ingrowth

    APPROXIMATELY 2 MONTH(S) AND 12 DAY(S) POST-OPERATIVE OF A RIGHT RTSA, IT WAS REPORTED VIA CLINICAL STUDY THAT THE PATIENT EXPERIENCED ASEPTIC GLENOID LOOSENING. PATIENT NOTICED INCREASED PAIN AND DECREASED MOTION WITHOUT REPORTED INCITING EVENT. X-RAYS AND CT SCAN CONFIRM ASEPTIC GLENOID LOOSENING. IT WAS NOTED IN THE PATIENTS MEDICAL HISTORY, A FURTHER DIAGNOSIS OF HUMERAL STEM LOOSENING. THERE WERE ALSO NOTATIONS REGARDING PREVIOUS EVENTS OF EXTENSIVE DEBRIDEMENT; HEMIARTHROPLASTY (BIOLOGICAL GLENOID W/HUMERAL RESURFACING); REVISION OF HEMI TO TSA W/POLY GLENOID; REVISION TO RTSA W/ALLOGRAFTING TO GLENOID; AND REMOVAL OF IMPLANTS, ABX SPACER, AND DEBRIDEMENT PRIOR TO THE ONSET OF THE LOOSENING EVENT. THE PATIENT UNDERWENT STANDARD REVERSE WITH HUMERAL RECONSTRUCTION STEM REVISION WITH THE REPORTED REMOVAL OF THE TORQUE SCREW, HUMERAL TRAY, HUMERAL LINER, GLENOSPHERE, GLENOSPHERE LOCKING SCREW, GLENOID BASE PLATE, AND COMPRESSION SCREW/LOCKING CAP. THE PATIENT WAS BONE GRAFTED ON THE GLENOID SIDE USING ILIAC CREST AUTOGRAFT AND DONOR ALLOGRAFT. GLENOSPHERE WAS NOT PLACED. PATIENT WILL HAVE CT SCAN AT 3 MONTHS TO ASSESS HEALING. IF THERE IS CONSOLIDATION OF THE GRAFT AND THE BASEP

    Patient problems: Loss of Range of Motion; Pain

    MAUDE report 20777651 ↗

Other Prosthesis, Shoulder, Hemi-, Humeral, Metallic Uncemented devices

All Prosthesis, Shoulder, Hemi-, Humeral, Metallic Uncemented devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page